本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Janux Therapeutics, Inc.

28.72
-0.5600-1.91%
盘后28.760.0400+0.14%18:57 EST
成交量:92.68万
成交额:2,688.85万
市值:17.27亿
市盈率:-17.09
高:29.94
开:28.95
低:28.34
收:29.28
52周最高:71.71
52周最低:21.73
股本:6,014.78万
流通股本:4,496.69万
量比:1.13
换手率:2.06%
股息:- -
股息率:- -
每股收益(TTM):-1.6802
每股收益(LYR):-1.2836
净资产收益率:-12.48%
总资产收益率:-10.49%
市净率:1.77
市盈率(LYR):-22.38

数据加载中...

2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]